Characteristics and risk factors of major and clinically relevant non-major bleeding in cancer patients receiving anticoagulant treatment for acute venous thromboembolism - the CATCH study

被引：0
|
作者：
Kamphuisen, P. W. [1 ]
Lee, A. Y. Y. [2 ,3 ]
Meyer, G. [4 ]
Bauersachs, R. [5 ]
Janas, M. S. [6 ]
Jarner, M. F. [6 ]
Khorana, A. A. [7 ]
机构：
[1] Univ Med Ctr Groningen, Dept Vasc Med, NL-9713 AV Groningen, Netherlands
[2] Univ British Columbia, Div Hematol, Vancouver, BC V5Z 1M9, Canada
[3] Vancouver Coastal Hlth, Vancouver, BC, Canada
[4] Georges Pompidou European Hosp, Resp Unit, Paris, France
[5] Darmstadt Hosp, Dept Vasc Med, Darmstadt, Germany
[6] LEO Pharma, Ballerup, Denmark
[7] Cleveland Clin Fdn, Taussig Canc Inst, Cleveland, OH 44195 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2015年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OR228
引用
收藏
页码：182 / 183
页数：2
相关论文
共 50 条
  • [31] The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment
    Kooiman, Judith
    van Hagen, Nadja
    del Sol, Antonio Iglesias
    Planken, Erwin V.
    Lip, Gregory Y. H.
    van der Meer, Felix J. M.
    Cannegieter, Suzanne C.
    Klok, Frederikus A.
    Huisman, Menno V.
    PLOS ONE, 2015, 10 (04):
  • [32] Apixaban reduces the risk of major and clinically relevant non-major bleeding compared to warfarin in patients with end stage renal disease; a systematic review and meta-analysis of ten studies
    Zagoridis, Konstantinos
    Karatisidis, Lazaros
    Mprotsis, Theodoros
    Pentidou, Aikaterini
    Bezirgianidou, Zoi
    Misidou, Christina
    Spanoudakis, Emmanouil
    THROMBOSIS RESEARCH, 2023, 231 : 17 - 24
  • [33] Impact of chronic kidney disease and treatment with LMWH on the risk of major bleeding in patients with cancer-associated venous thromboembolism
    Kooiman, J.
    Den Exter, P. L.
    Cannegieter, S. C.
    Le Cessie, S.
    Del Toro, J.
    Sahuquillo, J. C.
    Pedrajas, J. M.
    Huisman, M., V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 985 - 985
  • [34] Risk Factors of Unfavorable Outcomes, Major Bleeding, and All-Cause Mortality in Patients with Venous Thromboembolism
    Lee, Han Young
    Yeo, Tae Floon
    Heol, Tae Kyung
    Cho, Young Gyu
    Cho, Dong Hui
    Lee, Kyung Bok
    VASCULAR SPECIALIST INTERNATIONAL, 2021, 37
  • [35] Time Course and Subsequent Outcomes of Major Bleeding Events According to Bleeding Site in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism: Insights from the RIETE Registry
    Bikdeli, Behnood
    Nieto, Jose Antonio
    Moustafa, Fares
    Ruiz-Gimenez, Nuria
    Lorenzo, Alicia
    Schellong, Sebastian
    Soler, Silvia
    Morales, Maria Del Valle
    Bosevski, Marijan
    Gavin, Olga
    Monreal, Manuel
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2019, 39
  • [36] The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism
    Caiano, Lucia
    Kovacs, Michael J.
    Lazo-Langner, Alejandro
    Anderson, David R.
    Kahn, Susan R.
    Shah, Vinay
    Kaatz, Scott
    Zide, Russell S.
    Schulman, Sam
    Chagnon, Isabelle
    Mallick, Ranjeeta
    Rodger, Marc A.
    Wells, Philip S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2023, 21 (03) : 553 - 558
  • [37] Risk of major and clinically relevant non-major (CRNM) bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular AF (SPAF) and the prevention and/or treatment of deep vein thrombosis and/or pulmonary embolism (DVT/PE) in primary care in England
    Dhanda, Sandeep
    Davies, Miranda
    Roy, Debabrata
    Wise, Lesley
    Shakir, Saad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 8 - 8
  • [38] Occurrence rates and risk factors of in-hospital venous thromboembolism, major bleeding, and death in patients receiving fondaparinux after orthopedic surgery or trauma surgery
    Ya Ding
    Bowen Han
    Bin Yuan
    Mingjun Nie
    Renyang Liu
    Ming Zhao
    Hongliang Wang
    Irish Journal of Medical Science (1971 -), 2023, 192 : 2973 - 2979
  • [39] Occurrence rates and risk factors of in-hospital venous thromboembolism, major bleeding, and death in patients receiving fondaparinux after orthopedic surgery or trauma surgery
    Ding, Ya
    Han, Bowen
    Yuan, Bin
    Nie, Mingjun
    Liu, Renyang
    Zhao, Ming
    Wang, Hongliang
    IRISH JOURNAL OF MEDICAL SCIENCE, 2023, 192 (06) : 2973 - 2979
  • [40] Risk factors of recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism: from the COMMAND VTE Registry
    Yamashita, Y.
    Amano, H.
    Morimoto, T.
    Kimura, T.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1937 - 1937
12345